Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 12, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 12, 2019Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 21, 2017Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 29, 2021Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:October 10, 2023Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:August 30, 2016Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:September 15, 2015Completed
Condition(s):Chronic Myelogenous Leukemia – Chronic PhaseLast Updated:November 30, 2023Recruiting
Condition(s):Philadelphia Chromosome Positive; Chronic Myelogenous Leukemia in Chronic PhaseLast Updated:April 8, 2016Completed
Condition(s):Chronic Myeloid Leukemia (CML); Chronic PhaseLast Updated:October 10, 2018Unknown status
Condition(s):Chronic Myelocytic LeukemiaLast Updated:November 4, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.